Multiple studies suggest that atopic dermatitis disease progression can be primarily attributed to immune response dysfunction, which is attenuated by activation of JAK-STAT signaling (Sarapultsev et al., 2023). This evidence concerns the gene SOAT1 and atopic eczema.